SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 16.85 |
| Enterprise Value ($M) | 15.75 |
| Book Value ($M) | 3.25 |
| Book Value / Share | 0.15 |
| Price / Book | 5.19 |
| NCAV ($M) | -3.18 |
| NCAV / Share | -0.15 |
| Price / NCAV | -5.30 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.46 |
| Return on Assets (ROA) | -1.35 |
| Return on Equity (ROE) | -2.72 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.91 |
| Current Ratio | 0.97 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 8.98 |
| Assets | 15.41 |
| Liabilities | 12.16 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.90 |
| Operating Income | -26.64 |
| Net Income | -26.30 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -21.94 |
| Cash from Investing | -1.90 |
| Cash from Financing | 14.23 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | KfW | 6.40 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 48,744 | 186,044 | 26.20 | |
| 34,195 | 138,129 | 24.76 | |
| 2,250 | 24,111 | 9.33 | |
| 99,239 | 61,771 | 160.66 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MRKR – Marker Therapeutics, Inc. | MTEM – Molecular Templates, Inc. |
| MYMD – MyMD Pharmaceuticals, Inc. | NATR – Nature's Sunshine Products, Inc. |
| NBSE – NeuBase Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io